In partnership with
September 26, 2025
Built by a former cannabis regulator, Policy, Decoded is your high-signal daily briefing for operators, investors, and policymakers navigating the collision of law, regulation, and business.
Today’s edition is brought to you by 1440 Media, the daily newsletter trusted by over 3 million readers for fact-focused news.
THC testing fraud has gone mainstream, with lab shopping and potency inflation exposed in national headlines. Minnesota’s first licensed cannabis festival showcased how regulation can merge commerce with culture, while Tax Court delivered another 280E blow. Elsewhere, pediatric cannabis hospitalizations spiked in Massachusetts, German data undermined prohibitionist fears, and Texas locked THC products under liquor rules.
🧪 THC testing scandal goes public
🎵 Minnesota cannabis + culture
⚖️ Another 280E tax setback
Enjoy the weekend. Stay sharp.
Looking for unbiased, fact-based news? Join 1440 today.
Join over 4 million Americans who start their day with 1440 – your daily digest for unbiased, fact-centric news. From politics to sports, we cover it all by analyzing over 100 sources. Our concise, 5-minute read lands in your inbox each morning at no cost. Experience news without the noise; let 1440 help you make up your own mind. Sign up now and invite your friends and family to be part of the informed.
Start here — the day’s most important development, decoded for impact.
📌 What Happened: High Times published an exposé documenting systematic THC percentage inflation across legal cannabis markets, confirming what industry insiders have whispered about for years. The widespread "lab shopping" where cultivators seek testing facilities willing to provide inflated results has created a market built on lies. Academic research validates these concerns with multi-state studies finding actual THC levels 35-50% below labeled percentages, affecting 60-87% of tested products. The fraud goes deeper than potency manipulation. Massachusetts discovered one laboratory concealed contamination failures in 25% of the state's cannabis supply. California prevented 480 contaminated batches from reaching consumers in 2024 alone. Major enforcement actions swept through the industry this year with California revoking four laboratory licenses, Massachusetts suspending its first facility ever, and Oregon taking action against seven of its eleven licensed labs. Consumer lawsuits now challenge inflated THC claims while federal agencies explicitly cite testing inconsistencies as barriers to cannabis rescheduling and interstate commerce development.
💡 Why It Matters: This testing manipulation is the logical endpoint of state-legal markets that regulators built under impossible conditions, forced to create oversight frameworks without federal guidance while managing industry pressure and limited resources. The scheme creates direct consumer health risks through contaminated products bypassing safety protocols. THC inflation undermines medical dosing accuracy and recreational consumer expectations, validating prohibitionist arguments about industry dishonesty at the worst possible time. Federal policymakers specifically reference testing integrity problems as barriers to rescheduling decisions, interstate commerce development, and banking access. This crisis threatens industry legitimacy during critical reform negotiations. The economic consequences cascade across supply chains where honest laboratories lose clients to fraudulent competitors, creating a race-to-the-bottom dynamic that punishes integrity while rewarding deception. Most critically, the fragmented state-by-state regulatory approaches lack coordination mechanisms to address systematic fraud spanning multiple jurisdictions, preventing the unified federal standards that enable pharmaceuticals, alcohol, and tobacco to operate efficient interstate markets.
🧠 THC Group Take: This testing manipulation represents the logical endpoint of state-legal markets that regulators built under impossible conditions, forced to create oversight frameworks without federal guidance while managing industry pressure and limited resources. The fraud creates direct consumer health risks through contaminated products bypassing safety protocols. THC inflation undermines medical dosing accuracy and recreational consumer expectations, validating prohibitionist arguments about industry dishonesty at the worst possible time. Federal policymakers specifically reference testing integrity problems as barriers to rescheduling decisions, interstate commerce development, and banking access. This crisis threatens industry legitimacy during critical reform negotiations. The economic consequences cascade across supply chains where honest laboratories lose clients to fraudulent competitors, creating a race-to-the-bottom dynamic that punishes integrity while rewarding deception. Most critically, the fragmented state-by-state regulatory approaches lack coordination mechanisms to address systematic fraud spanning multiple jurisdictions, preventing the unified federal standards that enable pharmaceuticals, alcohol, and tobacco to operate efficient interstate markets.
Fast-moving headlines, flagged for what matters.
Smart Approaches to Marijuana released a poll claiming Americans oppose cannabis rescheduling, using the kind of loaded questions that would make a prosecutor coaching a witness proud. The survey asked respondents whether they'd support rescheduling if it would give marijuana companies "a financial incentive to advertise more to children," a premise about as honest as asking if you'd support restaurants because they might poison customers. NORML's Morgan Fox called out prohibitionists for their "creative interpretations of data," which is polite speak for statistical malpractice. The desperate tactics contradict legitimate surveys including one by Trump-associated firm Fabrizio, Lee & Associates showing majority Republican support for rescheduling. When your movement's reduced to crafting fantasy scenarios about predatory cannabis marketers stalking playgrounds, you've already lost the policy argument and whatever intellectual honesty you started with. (Marijuana Moment)
Minnesota just issued its first cannabis event license to a hip-hop festival featuring artists who've made careers celebrating the plant, creating the kind of cultural validation that prohibition states can't replicate. The Legacy Cup Festival will allow on-site sales and consumption at this weekend's event, demonstrating how sophisticated regulatory frameworks can accommodate both commerce and culture in controlled settings. This milestone timing - just one week after the state's first dispensaries opened - shows Minnesota's deliberate market orchestration rather than the chaotic rollouts plaguing other states. The real strategic advantage here isn't the novelty but geography: Minnesota sits surrounded by prohibition states, positioning these early venues to capture significant cross-border revenue while neighboring jurisdictions debate basic decriminalization. Event licensing represents the kind of nuanced policy tool that separates mature cannabis markets from simple dispensary-and-done approaches. (Marijuana Moment)
Minnesota beer volumes fell 6.3 percent year-over-year through June 2025, with craft down 9 percent, as the state's hemp-derived THC beverage market matures three years post-legalization. Nearly 70 percent of craft brewers now pursue THC licensing, with some operators seeing hemp beverages reach 12 percent of portfolio while beer drops to single digits. The data represents the clearest early signal of substitution effects as THC beverages scale beyond novelty into mainstream retail channels. Municipal liquor stores posted record $437 million sales in 2024, their first full year selling THC products, confirming adult-use cannabis derivatives can drive meaningful revenue displacement in established alcohol markets. (VinePair)
The preliminary injunction we've been tracking since July's measurement fiasco is now official, with a New York judge granting dispensaries relief until February 2026. The Hochul administration's decision to support operators in this case represents a stunning about-face, essentially asking the court to sanction continued regulatory lawbreaking while waiting for a legislative fix. OCM's three-year measurement error now requires judicial intervention to prevent market chaos, confirming our ongoing coverage about the program's structural incompetence. The real test comes when Albany reconvenes to determine whether lawmakers will actually prioritize cleaning up this mess. (Crain's New York)
Vermont regulators reached a settlement with Flora Cannabis that loosens the state's restrictive advertising rules while maintaining pre-approval requirements for all cannabis ads. The agreement allows stores to proceed with advertisements if regulators fail to respond within five days, permits social media promotion without images, and eliminates pre-approval requirements for in-store promotions. Flora Cannabis sued the state last year arguing that Vermont's advertising restrictions were the nation's strictest, requiring pre-approval even for in-store "20% off" signs while treating cannabis businesses more harshly than alcohol or sports betting operators. The settlement represents a tactical retreat by Vermont regulators who faced a constitutional challenge they likely couldn't win, particularly after other states have lost similar free speech cases. Cannabis Control Board Chair James Pepper called it a "good compromise" that reduces administrative burden without opening social media floodgates, though Flora's owner promises to push for additional changes when the legislature reconvenes. (Vermont Public)
A NIDA-funded study published in the Journal of Adolescent Health found that Snapchat's AI readily provides information about delta-8 THC and alcohol while blocking marijuana queries, despite the platform's stated policy of blocking "results for drug keywords." Researchers from George Washington University and University of North Texas tested responses to both adult and 13-year-old accounts, discovering the AI provided retail locations and favorable attitudes toward delta-8 THC without citations or evidence-based claims. The inconsistent enforcement directly undermines Snapchat's content policies while potentially steering users toward less-regulated hemp cannabinoids that experts consider riskier than conventional cannabis due to limited safety research. The platform's algorithmic gatekeeping creates a perverse incentive structure where federally legal but poorly understood substances receive promotional treatment while state-legal adult-use cannabis remains censored. This regulatory arbitrage through AI content policies demonstrates how platform governance decisions now function as de facto drug policy, shaping consumer behavior independent of actual legal frameworks or public health evidence. (Marijuana Moment)
The Tax Court ruled in Savage v. Commissioner that cannabis businesses cannot count wages disallowed under Section 280E toward their Section 199A qualified business income deduction, effectively reducing the 20% pass-through deduction available to other business owners. The September 11 decision means marijuana operators face a double penalty where wages cannot be deducted as business expenses under 280E and simultaneously cannot support the income-based tax rate reduction that partnerships and S corporations typically enjoy. This ruling compounds the existing tax burden on cannabis operators who already face effective rates exceeding 60% compared to standard corporate rates of 21%. The decision follows a consistent pattern of Tax Court hostility toward any cannabis tax relief, building on previous cases that denied deductions for employee wage corporations and non-marijuana business activities. Cannabis operators now confront what amounts to a cascading tax penalty system where Section 280E restrictions create additional limitations across multiple areas of the tax code. (National Law Review)
From the hearing room to the comment section — we’re watching it all.
🖊️ GOP discovers comedy gold in Biden's cannabis fumble, turning rescheduling delays into autopen punchlines while conveniently ignoring decades of their own party blocking any marijuana reform. The joke writes itself when Republicans mock presidential pen usage while simultaneously urging completion of the very policy they spent generations opposing. (Marijuana Moment)
🏥 Wisconsin cannabis advocates continue hammering the opioid comparison as Republican legislative leaders signal potential movement on medical cannabis after years of obstruction. The 86% polling support and surrounding state legalization create political pressure that even gerrymandered districts can't ignore forever, though the pace suggests Wisconsin will remain stubbornly behind its neighbors. (Madison.com)
🍑 Georgia families continue their decade-long advocacy at the statehouse, sharing personal stories and medical evidence as lawmakers study expanding the state's restrictive cannabis program beyond its current 25,000 patients. The persistence is paying off as conservative legislators increasingly recognize that compassionate medical access doesn't equal recreational legalization. (13wmaz.com)
📦 The cannabis packaging market is projected to balloon from $1.4 billion to over $9 billion by 2030, driven by state legalization rollouts and increasingly sophisticated compliance requirements. What started as simple mason jars has evolved into a specialized industry where child-resistant, tamper-evident, and sustainable packaging commands premium pricing in a market that didn't exist a decade ago. (OpenPR)